ATE284440T1 - Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation - Google Patents

Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation

Info

Publication number
ATE284440T1
ATE284440T1 AT01979646T AT01979646T ATE284440T1 AT E284440 T1 ATE284440 T1 AT E284440T1 AT 01979646 T AT01979646 T AT 01979646T AT 01979646 T AT01979646 T AT 01979646T AT E284440 T1 ATE284440 T1 AT E284440T1
Authority
AT
Austria
Prior art keywords
microbe
dampening
transcription
stopper
mutation containing
Prior art date
Application number
AT01979646T
Other languages
English (en)
Inventor
Roy Curtiss Iii
Steven A Tinge
Original Assignee
Univ St Louis
Megan Health Inc
Roy Curtiss Iii
Steven A Tinge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ St Louis, Megan Health Inc, Roy Curtiss Iii, Steven A Tinge filed Critical Univ St Louis
Application granted granted Critical
Publication of ATE284440T1 publication Critical patent/ATE284440T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT01979646T 2000-10-12 2001-10-11 Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation ATE284440T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68912300A 2000-10-12 2000-10-12
PCT/US2001/031606 WO2002030457A2 (en) 2000-10-12 2001-10-11 Microbes having an attenuating mutation comprising a transcription terminator

Publications (1)

Publication Number Publication Date
ATE284440T1 true ATE284440T1 (de) 2004-12-15

Family

ID=24767139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979646T ATE284440T1 (de) 2000-10-12 2001-10-11 Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation

Country Status (7)

Country Link
EP (1) EP1326960B1 (de)
AR (1) AR030882A1 (de)
AT (1) ATE284440T1 (de)
AU (1) AU2002211582A1 (de)
CA (1) CA2463482A1 (de)
DE (1) DE60107707T2 (de)
WO (1) WO2002030457A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004231129A1 (en) * 2003-04-18 2004-10-28 Warnex Research Inc. Oligonucleotides for the detection of salmonella species
WO2009025888A2 (en) 2007-05-10 2009-02-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
US8465755B2 (en) 2007-10-05 2013-06-18 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against enteric pathogens
WO2010045620A1 (en) 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
US9163219B2 (en) 2009-04-14 2015-10-20 Arizona Board Of Regents On Behalf Of Arizona State University Single expression vector for generation of a virus with a segmented genome
WO2010135563A1 (en) 2009-05-22 2010-11-25 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium and methods of antigen and nucleic acid delivery
US9045742B2 (en) 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9062297B2 (en) 2010-01-13 2015-06-23 The Arizona Board Of Regents For And On Behalf Of Arizona State University Yersinia pestis vaccine
WO2011091291A1 (en) 2010-01-22 2011-07-28 The Arizona Board Of Regents For And On Behalf Of Arizona State University BACTERIUM COMPRISING A REGULATED rfaH NUCLEIC ACID
US9598697B2 (en) 2010-05-28 2017-03-21 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium to decrease tumor growth
US9303264B2 (en) 2012-05-18 2016-04-05 The Arizona Board Of Regents For And On Behalf Of Arizona State University Photosynthetic microorganisms expressing thermostable lipase
US9580718B2 (en) 2013-06-17 2017-02-28 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated live bacteria with increased acid resistance and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0912724B1 (de) * 1996-07-15 2009-12-09 The Government of The United States of America, as represented by The Department of Health and Human Services Herstellung von attenuierten respiratorischen syncytialvirus-impfstoffen aus klonierten nukleotidsequenzen
GB9804809D0 (en) * 1998-03-06 1998-04-29 Wallis Timothy S Attenuated salmonella:materials and methods relating thereto

Also Published As

Publication number Publication date
EP1326960A2 (de) 2003-07-16
DE60107707D1 (de) 2005-01-13
WO2002030457A2 (en) 2002-04-18
AU2002211582A1 (en) 2002-04-22
WO2002030457A9 (en) 2003-07-24
WO2002030457A3 (en) 2003-01-23
EP1326960B1 (de) 2004-12-08
DE60107707T2 (de) 2005-12-08
CA2463482A1 (en) 2003-04-18
AR030882A1 (es) 2003-09-03

Similar Documents

Publication Publication Date Title
DE60137807D1 (de) Anrufverwaltungssystem mit einer dynamischen Warteschlangenposition
DE50206750D1 (de) System mit einer werkzeugaufnahme
DE60129959D1 (de) Abgabeverschluss mit originalitätsdeckel
PT1341791E (pt) Imidazoquinolinas substituidas com tioeter
PT1043239E (pt) Recipiente com lados colapsaveis
DE60124631D1 (de) Vorrichtung zur Dämpfung von Drehmomentschwankungen mit einer Struktur zur Verringerung von Ausrichtungsfehlern des Drehmomentbegrenzers beim Zusammenbau
DE60238180D1 (de) Strukturbildungsverfahren mit einer fotomaske
DE60121430D1 (de) Ändern des hypermediainhalts einer webseite
DE60123163D1 (de) Auftragen einer klaren Deckflüssigkeit
DE60140070D1 (de) Verschliessen einer flachtafelvorrichtung
DE60124877D1 (de) Katheter mit einer speerförmigen spitze
DE60107707D1 (de) Mikroben mit einer transkriptionsabbrecher enthaltender dämpfender mutation
DE60114915D1 (de) Begrenztes Drucken einer elektronisch übertragenen Information
DE60126877D1 (de) D/A-Wandler
DE50108130D1 (de) Drosselklappensteller
DE60121607D1 (de) Gerät zur protokollübersetzung mit hilfe eines generischen zwischenprotokolls
DE60104785D1 (de) Tintenbehälter
DE50104338D1 (de) Falzapparat mit einer Weiche
ATA9712000A (de) Mehrkammertank
DE60108041D1 (de) Aufzeichnungsblatt
DE50203659D1 (de) Schaltschiene mit einer Schaltgabel
ITMI20001513A0 (it) Micomelanine a struttura polinaftoica
EP1355745A4 (de) Anlaufschutzüberzüge mit haftungsverbesserung
DE50309391D1 (de) Mikroskop mit einer Fokussiereinrichtung
DE60209079D1 (de) Durchlässig Aufzeichnungsträger mit einer glänzenden Beschichtung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties